These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8207563)
41. The salt-fed animal as a test object for pressor substances in the blood of hypertensive animals. GORDON DB; DRURY DR; SCHAPIRO S Am J Physiol; 1953 Oct; 175(1):123-8. PubMed ID: 13114364 [No Abstract] [Full Text] [Related]
42. The link between cytosolic Ca2+ and the Na+-H+ antiport: a unifying factor for essential hypertension. Aviv A J Hypertens; 1988 Sep; 6(9):685-91. PubMed ID: 2972768 [No Abstract] [Full Text] [Related]
43. Network and 16S rRNA Sequencing-Combined Approach Provides Insightal Evidence of Vitamin K Liu TH; Chen MH; Tu WQ; Liang QE; Tao WC; Jin Z; Xiao Y; Chen LG Front Nutr; 2021; 8():639467. PubMed ID: 33718421 [TBL] [Abstract][Full Text] [Related]
44. The cellular ionic basis of hypertension and allied clinical conditions. Resnick L Prog Cardiovasc Dis; 1999; 42(1):1-22. PubMed ID: 10505490 [TBL] [Abstract][Full Text] [Related]
45. The calcium deficiency hypothesis of hypertension: a critique. Kaplan NM; Meese RB Ann Intern Med; 1986 Dec; 105(6):947-55. PubMed ID: 3535609 [TBL] [Abstract][Full Text] [Related]
46. The calcium deficiency hypothesis of hypertension. McCarron DA; Morris CD Ann Intern Med; 1987 Dec; 107(6):919-22. PubMed ID: 3318612 [TBL] [Abstract][Full Text] [Related]
47. The parathyroid hypertensive factor--facts and future. Hansson L; Hedner T; Jern S Blood Press; 1994 May; 3(3):147. PubMed ID: 8069401 [No Abstract] [Full Text] [Related]
48. Parathyroid Hypertensive Factor: A New Circulating Substance in Essential Hypertension. Proceedings of a satellite symposium to the 14th ISH meeting. Madrid, Spain, June 13, 1992. J Cardiovasc Pharmacol; 1994; 23 Suppl 2():S1-49. PubMed ID: 7518537 [No Abstract] [Full Text] [Related]
49. Calcium as a mediator of salt sensitive hypertension. Resnick LM Adv Exp Med Biol; 1986; 208():397-404. PubMed ID: 3551540 [No Abstract] [Full Text] [Related]
50. Research issues and ethnic implications in essential hypertension. Mensah GA J Assoc Acad Minor Phys; 1991; 2(4):168-73. PubMed ID: 1811821 [TBL] [Abstract][Full Text] [Related]
51. Salt intake and hypertension. PHEAR DN Br Med J; 1958 Dec; 2(5110):1453. PubMed ID: 13596641 [No Abstract] [Full Text] [Related]
52. The evaluation of the hypertensive patient. LAUER DJ Mo Med; 1962 May; 59():412-7. PubMed ID: 14462735 [No Abstract] [Full Text] [Related]
53. [Results of conferences on the problems of hypertensive disease]. GUKASZJAN AG Orv Hetil; 1952 Jul; 93(29):825-31. PubMed ID: 13003357 [No Abstract] [Full Text] [Related]
54. [Studies on hypertensive reactions]. SMOTROV AN Klin Med (Mosk); 1952 Dec; 30(12):50-3. PubMed ID: 13035991 [No Abstract] [Full Text] [Related]
58. Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones. Yusuf J; Khan MU; Cheema Y; Bhattacharya SK; Weber KT Prog Cardiovasc Dis; 2012; 55(1):77-86. PubMed ID: 22824113 [TBL] [Abstract][Full Text] [Related]
59. Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney disease. Vaidya A; Forman JP Curr Hypertens Rep; 2012 Apr; 14(2):111-9. PubMed ID: 22328068 [TBL] [Abstract][Full Text] [Related]
60. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Vaidya A; Williams JS Metabolism; 2012 Apr; 61(4):450-8. PubMed ID: 22075270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]